Stocks and Investing Stocks and Investing
Thu, July 7, 2022

Graig Suvannavejh Initiated (ATHA) at Strong Buy and Held Target at $6 on, Jul 7th, 2022


Published on 2024-10-27 21:47:25 - WOPRAI, Graig Suvannavejh
  Print publication without navigation


Graig Suvannavejh of Mizuho, Initiated "Athira Pharma, Inc." (ATHA) at Strong Buy and Held Target at $6 on, Jul 7th, 2022.

Graig has made no other calls on ATHA in the last 4 months.



There are 5 other peers that have a rating on ATHA. Out of the 5 peers that are also analyzing ATHA, 3 agree with Graig's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Andrew Tsai of "Jefferies" Downgraded from Strong Buy to Hold and Decreased Target to $3 on, Thursday, June 23rd, 2022
  • Jason Butler of "JMP Securities" Downgraded from Buy to Hold on, Thursday, June 23rd, 2022
  • Paul Matteis of "Stifel" Downgraded from Strong Buy to Hold and Decreased Target to $5 on, Thursday, June 23rd, 2022


These are the ratings of the 2 analyists that currently disagree with Graig


  • Thomas Shrader of "BTIG" Initiated at Strong Buy and Held Target at $33 on, Tuesday, May 10th, 2022
  • Esther Hong of "Berenberg" Initiated at Strong Buy and Held Target at $33 on, Thursday, April 21st, 2022
Contributing Sources